Back to User profile » Dr Linda Wase
Papers published by Dr Linda Wase:
Original Research
![Noteworthy comment: Great example of clinical use of a compound demonstrating agonist directed trafficking- reduced recruitment of b-arrestin. This is particularly relevant in the current climate as this study focuses on an opioid agonist that could yield less development of tolerance in the real world and possibly lead to a lower required dose. This is extremely relevant for all of those involved in pain treatment.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy
Bergese SD, Brzezinski M, Hammer GB, Beard TL, Pan PH, Mace SE, Berkowitz RD, Cochrane K, Wase L, Minkowitz HS, Habib AS
Journal of Pain Research 2019, 12:3113-3126
Published Date: 14 November 2019
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
APOLLO-1: a randomized placebo and active-controlled phase III study investigating oliceridine (TRV130), a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy
Viscusi ER, Skobieranda F, Soergel DG, Cook E, Burt DA, Singla N
Journal of Pain Research 2019, 12:927-943
Published Date: 11 March 2019